Skip to main content

Kodak’s stock triples as company announces pandemic plan to start making pharmaceutical ingredients

The Trump administration’s $765 million loan to the Eastman Kodak Co. to launch a business making pharmaceutical ingredients sent shares of the once iconic camera company soaring.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.